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Introduction: Extracellular matrix proteins play a crucial role in inﬂuencing the invasion of trophoblast
cells. However the role of collagens and collagen type IV (col-IV) in particular at the implantation site is
not clear.
Methods: Immunohistochemistry was used to determine the distribution of collagen types I, III, IV and VI
in endometrium and decidua during the menstrual cycle and the ﬁrst trimester of pregnancy. Expression
of col-IV alpha chains during the reproductive cycle was determined by qPCR and protein localisation by
immunohistochemistry. The structure of col-IV in placenta was examined using transmission electron
microscopy. Finally, the expression of col-IV alpha chain NC1 domains and collagen receptors was
localised by immunohistochemistry.
Results: Col-IV alpha chains were selectively up-regulated during the menstrual cycle and decidualisa-
tion. Primary extravillous trophoblast cells express collagen receptors and secrete col-IV in vitro and
in vivo, resulting in the increased levels found in decidua basalis compared to decidua parietalis. A novel
expression pattern of col-IV in the mesenchyme of placental villi, as a three-dimensional network, was
found. NC1 domains of col-IV alpha chains are known to regulate tumour cell migration and the selective
expression of these domains in decidua basalis compared to decidua parietalis was determined.
Discussion: Col-IV is expressed as novel forms in the placenta. These ﬁndings suggest that col-IV not only
represents a structural protein providing tissue integrity but also inﬂuences the invasive behaviour of
trophoblast cells at the implantation site.
© 2014 Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The cycling endometrium undergoes extensive tissue remodel-
ling in preparation for the implantation of the blastocyst. This
process, known as decidualisation, occurs in response to changing
levels of estrogen and progesterone [1,2]. After embryo attachment,
trophoblast, derived from trophectoderm, differentiates into two
cellular layers. Villous cytotrophoblast cells form the inner layer
surrounding the placental villi and these fuse to form overlying
syncytiotrophoblast. Proliferation of villous cytotrophoblast results
in cell columns, which attach to the mucosal lining and invade
decidual tissue as extravillous trophoblast cells (EVT) [3,4]. These
play a key role in early placentation by remodelling maternal spiral
arteries to ensure sufﬁcient blood ﬂow to the developing fetus [5].
Insufﬁcient trophoblast invasion during early pregnancy is associ-
ated with pregnancy complications such as pre-eclampsia, fetals article under the CC BY-NC-ND lgrowth restriction and recurrent miscarriage [6,7]. Interactions of
components of decidua such as the extracellular matrix (ECM) are
known to regulate the correct degree of EVT invasion [3,8].
Decidualisation and trophoblast invasion are accompanied by
extensive remodelling of the ECM. Collagens are a major compo-
nent of the ECM scaffold, regulating cellular behaviour and deter-
mining the structural integrity of human tissue. To date, the
collagen family comprises 28 members, each assembling into su-
pramolecular structures to form ﬁbrils (collagen types I and III),
networks (collagen type IV) or beaded ﬁlaments (collagen type VI)
[9].
Collagen type IV (col-IV) is abundant in the lamina densa of all
basement membranes. Identiﬁed as the ﬁrst non-ﬁbre-forming
collagen, it provides structural support regulating adhesion,
migration and survival of cells [10]. Unlike other collagen types, the
polypeptide chains of human col-IV are encoded by six different
genes (COL4A1, COL4A2, COL4A3, COL4A4, COL4A5 and COL4A6)
[11e13]. The polypeptide chains consist of a cysteine- and lysine-
rich 7S domain at the N-terminus, a collagenous domain and a C-
terminal, glomerular non collagenous (NC1) domain [14]. The NC1icense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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trimers that further assemble into multidomains via their NC1 and
7S domains eventually giving rise to a two-dimensional network
organised in sheets. Networks of col-IV can be composed of three
distinct heterotrimeric molecules: [(a1(IV))2a2(IV)], [a3(IV)a4(IV)
a5(IV)] and [(a5(IV))2a6(IV)] of which [(a1(IV))2a2(IV)] is the pre-
dominant form present in most embryonic and adult basement
membranes [15]. There is increasing evidence that NC1 domains of
collagen molecules play important roles in cell migration, prolif-
eration and apoptosis [16e18]. Although col-IV NCI domains might
also affect the invasion of trophoblast, their expression in the
placental bed is not yet known.
The effects of ECM on cell behaviour are mediated by receptors
that speciﬁcally bind ECM components. At least six different groups
of collagen receptors have been identiﬁed: Integrins, discoidin
domain receptors (DDR), leukocyte-associated immunoglobulin
like receptors (LAIR), glycoprotein VI (GPVI), mannose-receptor
family and osteoclast-associated receptor (OSCAR) [19]. Among
these collagen receptors only the integrin heterodimers a1b1 and
a2b1 and soluble receptor LAIR-2 are known to be expressed by
trophoblast [20e22]. LAIR-2 is exclusively expressed by invading
trophoblast cells and is signiﬁcantly down-regulated in chorionic
villous samples from women who subsequently develop pre-
eclampsia [23,24]. Integrins alpha 10 (a10) and alpha 11 (a11)
and collagen receptors DDR-1 and DDR-2 that also bind to col-IV
and ﬁbril-forming collagens are linked with the progression of
various tumours via mediating cell migration [25e28]. The
expression of these collagen receptors at the fetalematernal
interface has not been described.
We have now studied the distribution of collagen types I, III, IV
and VI during the endometrial cycle and in the ﬁrst trimester of
pregnancy. Alpha(IV) chains are signiﬁcantly up-regulated in
secretory compared to proliferative endometrium. In vitro studies
also revealed secretion of col-IV by invading EVT resulting in
elevated levels of this collagen type at the implantation site
compared to decidua parietalis. We show a novel expression
pattern and the three-dimensional structure of this molecule in
placenta. Finally, the expression of col-IV NC1 domains and
collagen receptors in trophoblast is described. This study suggests
that col-IV does not simply function as a component of the base-
ment membrane but also regulates the migration of trophoblast
cells.
2. Methods
2.1. Tissue samples
Samples of ﬁrst trimester placental and decidual tissue were taken from routine
vaginal terminations of pregnancy (8e10 weeks gestation) as previously described
(King et al., 1989). Ethical approval for placenta and decidua was obtained from the
Cambridgeshire 2 Research Committee (reference no. 04/Q0108/23). For quantita-
tive real time PCR samples of proliferative and secretory endometrium were
collected at the University of Edinburgh. All patients provided written informed
consent and ethical approval was obtained from the Research Ethical Committee
(reference no. REC 07/S1103/29 and REC 10/S1402/59).
Human adult kidney was used as a positive control for antibodies against NC1
domains of alpha(IV) chains. Decidual and villous tissue fragments (1 cm2) were
snap frozen in O.C.T. (VWR chemicals) in liquid nitrogen. For parafﬁn-embedded
sections, tissue samples were embedded in 4% paraformaldehyde (PFA) overnight.
Tissue sections of 5 mm and 100 mmwere cut and stored at 20 C (frozen sections)
or room temperature (RT, parafﬁn-embedded sections) until required for
immunohistology.
2.2. Isolation of primary trophoblast cells
Trophoblast cells were isolated from placental samples from normal pregnan-
cies between 8 and 10 weeks of gestation using our well-established protocol.
Following overnight culture of the isolated cells on ﬁbronectin coated wells, this
typically yields cultures containing 70e90% HLA-Gþ trophoblast as determined by
ﬂow cytometry [29]. To determine collagen production, EVT were re-plated onto
uncoated BD Falcon cultures slides (BD, Becton Dickinson) and cultured for 48 h inHam's F12medium (Biosera) supplementedwith 20% fetal calf serum (FCS), 2 mM L-
glutamine, 10units/ml penicillin and 100 mg/ml streptomycin and 2 mg/ml
gentamycin.
2.3. Immunohistochemistry
Frozen tissue sections were ﬁxed in acetone for 5 min before staining. Parafﬁn-
embedded sections were de-parafﬁnized, dehydrated in a series of decreasing
concentrations of ethanol and re-hydrated in phosphate buffered saline (PBS). In-
cubation with Proteinase K (Dako) was used for antigen retrieval on parafﬁn-
embedded sections to detect collagen IV. Non-speciﬁc binding was blocked by
incubating sections with 2.5% serum of the species in which the secondary antibody
was raised. Sections were incubated with mouse antibodies to human collagen I
(COL-I, Abcam), collagen III (FH-7A, Abcam), collagen IV (CIV-22, Abcam), collagen VI
(3C4, Abcam), cytokeratin 7 (OV-TL 12/30, Dako), HLA-G (G233-216, Quantum Bio-
systems) and isotype control mouse IgG1 or mouse IgG2a (Biolegend and R&D,
respectively) for 30 min. These anti collagen antibodies have previously been shown
to recognize only the native triple helical forms of each of these collagens [30].
For the detection of collagen receptors, parafﬁn-embedded tissue sections were
subjected to heat-induced epitope retrieval (HIER) in either citrate or high pH TRIS
buffer using a pressure cooker (Menarini Diagnostics). Following blocking as above,
sections were incubated with anti-human integrin a10 (Millipore), anti-human
integrin a11 (Sigma), anti-human DDR-1 and DDR-2 (clones N1N3 and N2N3,
respectively, Genetex) and isotype control rabbit IgG (Sigma). Protein expression
was detected with biotinylated secondary antibodies followed by incubation with
streptavidinebiotin peroxidise complex (ABC reagent e Vector Laboratories) for
30 min. Peroxidase was visualized using 30diaminobenzidine (DAB, Sigma). Slides
were counterstained in Carazzi's haematoxylin. Images were taken with Leica
DC500 using the Leica IM50 software.
The intensity of collagen immunostaining in tissue sections was quantiﬁed using
ﬁve representative view ﬁelds of each slide and calculating the area of staining as a
percentage of the total area using a macro written in ImageJ (1.46r).
2.4. Immunoﬂuorescence staining
Cultured EVT were ﬁxed with 4% PFA for 15 min at RT. Fixed cells were blocked
with 1% fetal bovine serum and 2% normal goat serum in PBS. Following incubation
with ﬂuorescein isothiocyanate-labelled anti HLA-G (MEMG9-FITC, Serotec) over-
night at 4 C, ﬁxed cells and slides were incubated with anti collagen IV for 2 h at RT.
Alexa Fluor 568-conjugated secondary antibody together with DAPI (Sigma) were
applied for 1 h. Slides were mounted in Vectashield (Hard Set mounting medium,
Vector Laboratories). To determine the structure of col-IV in placenta and fetal
amniotic membrane, sections of 100 mm were cut and stained as above. All other
sections stained were 8 mm. To stain for alpha1-alpha6(IV) NC1 domains, antigen
retrieval was performed on frozen tissue sections by incubating sections with 6 M
urea, 0.1 M glycine, pH 3.3 for 30 min before blocking. Sections were incubated with
rat anti-human alpha1 e 6(IV) NC1 (clones H11, H21, H31, H43, H52, H63, Chondrex,
Inc.) followed by incubation with Alexa Fluor 568- or FITC-conjugated secondary
antibody together with DAPI for 1 h and samples were mounted in Vectashield. The
anti NC1 domain antibodies recognise the cryptic NC1 domains of the single
alpha(IV) chain. The speciﬁcity and characterization of these antibodies was shown
previously [31e33]. Adult kidneywas used as positive control tissue. Staining for the
collagen receptors was carried out by incubating sections with MEMG9-FITC as
described above, followed by the incubation with anti DDR-1 (R&D) and anti DDR-2
(R&D) overnight at 4 C. Sections were then incubated with Alexa Fluor 568-
conjugated secondary antibody to visualise DDR-1 or DDR-2 immunoreactivity
and mounted with DAPI as above. Images and z-stacks were acquired using a Zeiss
LSM 700 confocal microscope. Unless stated otherwise, all ﬂuorescence images
represent individual optical sections.
2.5. Transmission electron microscopy
Placental biopsies were ﬁxed in 4% glutaraldehyde in 0.1 M hydroxyethyl
piperazineethanesulfonic acid (HEPES) buffer at pH 7.4 for 12h at 4 C. The tissue
was rinsed in 0.1 M HEPES buffer followed by treatment with 1% osmium ferricya-
nide at RT for 2 h. Tissue was rinsed in water and treated with 2% uranyl acetate in
0.05Mmaleate buffer at pH 5.5 for 2 h at RT. Subsequently tissuewas rinsed inwater
and dehydrated in an ascending series of ethanol solutions from 70% to 100%, fol-
lowed by treatment with two changes of dry acetonitrile and inﬁltrationwith Quetol
651 epoxy resin. Images were taken in an FEI Tecnai G2 operated at 120 kV using an
AMT XR60B digital camera running Deben software.
2.6. Quantitative real-time RT-PCR
Ten proliferative endometrium, 13 secretory endometrium and 7 decidual
samples were used to investigate the transcript levels of alpha1-6(IV) chains. These
samples were dated as mid proliferative and mid secretory using Noyes' criteria and
conﬁrmed as consistent with the participant's reported last menstrual period and
serum levels of progesterone and estradiol collected at the time of biopsy.
The samples were ﬂash frozen in liquid nitrogen and total RNA was extracted
using Qiagen RNeasy Kit according to manufacturer's protocol. RNA samples were
Table 2
Immunostaining of collagen types I, III, IV and VI within uterus and placenta.a
Collagen type
I III IV VI
Endometrium Proliferative Stroma þ þ  þ
Basement membrane   þ 
Vessel wall þ þ þ þ
Myometrium þ þ þ þ
Secretory Stroma þ þ þ þþ
Basement membrane   þ 
Vessel wall þ þ þþ þ
Myometrium þ þ þ þ
Decidua Basalis Stroma þþ þþ þþþ þþ
Vessel wall þ þ þþ þ
Myometrium þ þ þ þ
Giant cell   þ 
Parietalis Stroma þþ þþ þ þþ
Vessel wall þ þ þ þ
C.M. Oefner et al. / Placenta 36 (2015) 59e68 61reverse transcribed to cDNA with the SuperScript VILO cDNA synthesis kit (Life
Technologies, Invitrogen) using a mix of oligo(dT) and random hexamer primers ac-
cording to manufacturer's instructions. qPCR experiments were carried out within
three months after the synthesis of cDNA. Primers were designed using Geneious
(Biomatters Ltd.) and the Primer-Blast program (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/). Melting temperatures and potential formation of secondary struc-
tures were tested using OligoCalc (http://www.basic.northwestern.edu/biotools/
OligoCalc.html). The primer speciﬁcity was conﬁrmed by sequencing PCR products.
Validated sequences are shown in Table 1. RT-PCR was carried out using Fast SYBR
greenmastermix and run on an ABI PRISM7700 sequence detection system according
to the manufacturer's instructions (Applied Biosystems, Warrington, UK) with
following cycle conditions: 95 C 20 s (1 cycle), 95 C 3 s and 60 C 30 s (40 cycles). A
dissociation curve was derived at the end of each run to check speciﬁcity. Controls
lacking template or reverse transcriptase were included to ensure no foreign or
genomic DNA contamination during preparations. Reference genes hRPL-19 and 18s
rRNA were used to normalise for the relative mRNA levels between samples. The
normalisation factor was gained by calculating the arithmetic mean of the relative
quantities of both reference genes [34]. Samples were run in duplicates and standard
curves for each target were prepared from pooled decidual samples. qPCR data was
analysed using the KruskaleWallis and Dunn's multiple comparisons test.Myometrium þ þ þ þ
Placenta Villous core þ þ þ þ
Fetal vessel wall þ þ þ þ
Basement membrane   þ þ
Cell column   þ 
a þ Present, þþ Strong, þþþ Very strong,  Absent.3. Results
3.1. Col-IV expression is up-regulated during the menstrual cycle
and early pregnancy
Immunohistochemistry was carried out to determine the
localisation of collagen types I, III, IV and VI during the menstrual
cycle and in the ﬁrst trimester of pregnancy using antibodies
detecting the native triple helical conformation of each collagen
(Table 2). Collagen types I, III, and VI are widely distributed
throughout the tissue (data not shown) with immunoreactivity in
vessel walls, myometrium and stroma of decidua basalis and
decidua parietalis and more intense staining in decidual compared
to endometrial stroma. In contrast, strong col-IV immunoreactivity
is conﬁned to basement membranes in mid-proliferative and mid-
secretory endometrium (Fig. 1). During the mid secretory phase,
col-IV immunostaining also appears around arteries in the sheaths
known as Streeter's columns where the ﬁrst changes of deciduali-
sation are seen (Fig. 1D). During the late secretory phase col-IV is
more evenly distributed in the stroma appearing as pericellular
staining around stromal cells (Fig. 1E, F).
Since these results suggest the hormonal regulation of col-IV,
quantitative real-time PCR was carried out for alpha1 e
alpha6(IV) chains (Fig.1G). COL4A5 and COL4A6 are signiﬁcantly up-
regulated in samples of mid secretory compared to mid prolifera-
tive endometrium and further increased in decidua. On the con-
trary, COL4A1, COL4A2, COL4A3 and COL4A4 are similar in mid
secretory and mid proliferative endometrium but are signiﬁcantly
up-regulated in decidua compared to endometrium. COL4A6 and
COL4A3 represent the most up-regulated transcripts in decidual vs.
proliferative endometrial samples (131-fold and 35-fold, respec-
tively). These results show that all alpha(IV) mRNAs are up-
regulated between secretory endometrium and decidua andTable 1
Primer sequences used for RT-PCR.
Gene Accession number Primer s
Sense 50
COL4A1 NM_001845.4 GTG CTG
COL4A2 NM_001846.2 GCC CAG
COL4A3 NM_000091.4 TCC CAG
COL4A4 NM_000092.4 TGA AGG
COL4A5 NM_000495.4 GCC TGG
COL4A6 NM_001847.2 TTC GGG
hRPL-19 NM_000981.3 CAA GCC
18s NR_003286.2 GCC TGCimmunohistochemistry shows this is reﬂected in increased staining
in the stroma and vessel walls.3.2. Primary trophoblast cells secrete col-IV in vitro
In decidua parietalis, native col-IV is present in basement
membranes, vessel walls and around individual decidual stromal
cells (Fig. 2A). In decidua basalis, characterised by the presence of
invading trophoblast cells, even more intense staining for col-IV is
noted (Fig. 2BeD). Quantiﬁcation of stained tissue sections reveals a
signiﬁcant increase in the expression of col-IV in decidua basalis vs.
parietalis (Fig. 2E). The expression pattern of native triple helical
col-IV in decidua was studied in more detail using immunoﬂuo-
rescence with monoclonal antibody CIV-22 (Fig. 2F,G). In decidua
parietalis col-IV immunostaining is pericellular around stromal
cells, whilst in decidua basalis there is additional dense deposition
around invading HLA-G þ EVT (Fig. 2G). To conﬁrm trophoblast do
express col-IV, primary trophoblast isolated from ﬁrst trimester
placenta were cultured and stained for HLA-G and native col-IV
(Fig. 2I). We conclude that HLA-Gþ trophoblast cells secrete this
collagen in vitro and contribute to the increased amount of col-IV
found at the implantation site.3.3. Distinctive col-IV structure in the placenta
In placental villi, native col-IV is typically present in the base-
ment membrane underlying villous trophoblast (Fig. 3B) but is alsoequence
e30 Antisense 50e30
TGT GTG AGG CGC GCC GAT CCA CAG CGA GGA
AGA GCC CAG CAA G CAG TCC CAC TTA GCC TCG G
GAA GAC AAG GCG C GGC ACC TGG GAA ACC TGG A
GAA ATC CCG GTG TG CAG GTG GCT CTA CCA ACA GG
GCT AAA GGG TCT AC CAA ACC ACG GGT ACC TGG C
ATG CCT GGA ATG CC GCT TTC TCT TGC CCC TCC AC
TGT GAC GGT CCA TT CTT CTC TGG CAT TCG GGC AT
GGC TTA ATT TGA CTC CAT GCC AGA GTC TCG TTC GTT
Fig. 1. The amount of col-IV increases during decidualisation. AeF Endometrial tissue sections, n ¼ 3 of each phase, were stained for col-IV using clone CIV-22. A, mid proliferative
(MP); C,D, mid secretory (MS); E,F, late secretory (LS) phase. Panel B, shows mid-proliferative endometrium stained with isotype control and is representative of all immuno-
histochemical investigations in this study. BM e basement membrane, G e gland, S e stroma, SA e spiral artery. G Ten proliferative endometrium (PE), 13 secretory endometrium
(SE) and seven decidual (D) samples were used to quantify relative levels of transcripts for COL4A1, COL4A2, COL4A3, COL4A4, COL4A5 and COL4A6 by real-time RTePCR through the
reproductive cycle. Samples were run in duplicate. Expression levels were measured relative to hRPL-19 and 18s. The graphs show mean expression levels in arbitrary units (AU).
Mean ± SD, ***P < 0.0001, **P < 0.001, *P < 0.005, ns e not signiﬁcant, determined using KruskaleWallis and Dunn's multiple comparisons test.
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Fig. 2. Col-IV is up-regulated at the implantation site and expressed by primary trophoblast cells in vitro. AeD Sections of decidua parietalis (A), n ¼ 3, and serial sections of decidua
basalis (BeD), n ¼ 3, were stained for col-IV (A, C, D) and cytokeratin 7 (CK7). Image D) represents the box in C). Scale bars 30 mm. E Area of col-IV immunostaining in decidua basalis
(DB) and decidua parietalis (DP) was quantiﬁed in ImageJ (n ¼ 3 for each). Mean ± SD, *P < 0.001 determined using Welch's t test. FeJ Confocal scanning microscopy images of
decidua parietalis (F), decidua basalis (G,H) and isolated primary trophoblast cells (I,J) stained for col-IV (red), HLA-G (green) and DAPI (blue). mIgG1-FITC negative control (H) and
isotype control for the anti-col-IV monoclonal antibody CIV-22, (J) show typical negative controls for immunoﬂuorescence staining. White open arrowheads (F,G) show the
expression of pericellular col-IV around individual stromal cells and white solid arrowheads show col-IV deposits around invading trophoblast cells (G). A e artery, CCC e cyto-
trophoblast cell column, D e decidua.
C.M. Oefner et al. / Placenta 36 (2015) 59e68 63present in large amounts in the mesenchyme of the villous core
(Fig. 3B) and as globules of intense staining in cytotrophoblast cell
columns (CCC) (Fig. 3C). These globules are present between HLA-
Gþ EVT, located in the distal part of the cell columns. Trans-
mission electron microscopy demonstrates the dense granular
nature of these globules attached to a trophoblast cell within CCC
(Fig. 3D). Confocal microscopy of 100 mm-thick tissue sections re-
veals the three-dimensional characteristics of col-IV in the villous
mesenchyme compared to fetal membrane, respectively (Fig. 3E, F).
In the villous mesenchyme col-IV forms a complex three-dimensional network encapsulating individual cells (Fig. 3E)
while forming a thin sheet underlining the basement membrane in
the amnion (Fig. 3F). There are therefore three different structural
forms of col-IV in placental villi suggesting that these have different
functions.
3.4. The expression of collagen IV NC1 domains in the placental bed
The C-terminus of col-IV chains (NC1 domains) play important
roles in diminishing cell migration resulting in decreased tumour
Fig. 3. Expression and structure of col-IV in placenta. AeC Serial sections of ﬁrst trimester placental villi, n ¼ 9, were stained for HLA-G (A) and native col-IV (B, C). Arrows in B)
show col-IV immunostaining in basement membranes. Image C) represents the box in B). Arrows in C) show globular col-IV in cytotrophoblast column. D Transmission electron
microscopy image of globules (arrows) attached to a trophoblast cell (T) in cytotrophoblast cell columns. E, F Confocal microscopy of 100 mm-thick sections comparing z-stack of
placental villous core (E) and fetal amniotic membrane (F) stained for col-IV (red) and DAPI (blue). Z-stack image of staining of serial sections with isotype-matched negative control
antibodies showed no detectable staining (data not shown). VC e villous core, CCC e cytotrophoblast cell column.
C.M. Oefner et al. / Placenta 36 (2015) 59e6864growth [17,35,36]. Since speciﬁc NC1 domains might have different
effects on the migratory behaviour of trophoblast cells, we per-
formed immunohistochemistry of the placental bed and decidua
parietalis using antibodies speciﬁc to the different alpha(IV) NC1
domains (summarised in Table 3). In comparison to the monoclonal
anti-col-IV antibody used above to detect the triple helical native
conformation of col-IV, these antibodies are directed against the
NC1 domains of single col-IV alpha chains. Representative pictures
for presence and absence of alpha(IV) NC1 domains are depicted in
Fig. 4.Table 3
Expression of alpha(IV)NC1 domains within the placental bed.a
Col-IV NC1 dom
Alpha1
Placenta Villous core þ
Basement membrane þ
Cell column þ
Decidua Basalis Stroma þ
Vessel wall þ
Parietalis Stromal cells þ
Vessel wall þ
a þ Present,  Absent.The NC1 domains from alpha1(IV), alpha2(IV), alpha3(IV) and
alpha5(IV) chains are present in the villousmesenchyme, basement
membranes of villi and CCC of the placenta. Alpha4(IV) NC1 domain
is absent from the placental bed. Some villi were devoid of
alpha6(IV) NC1 immunoreactivity while others stained weakly.
Alpha1-3(IV), alpha5(IV) and alpha6(IV) NC1 domains are present
in decidua basalis. In contrast, only alpha1(IV), alpha2(IV) and
alpha5(IV) NC1 domains are present in decidua parietalis. There is
therefore a selective presence of collagen type IV NC1 domains in
the placental bed.ains
Alpha2 Alpha3 Alpha4 Alpha5 Alpha6
þ þ  þ /þ
þ þ  þ 
þ þ  þ 
þ þ  þ þ
þ þ  þ þ
þ   þ 
þ   þ 
Fig. 4. Expression of alpha(IV) NC1 domains in the placental bed. Adjacent sections of placenta (AeC), n ¼ 3, decidua basalis (DeF), n ¼ 2, and human adult kidney as positive
control for alpha4(IV)NC1 (G), n ¼ 1, were stained for cytokeratin 7 (red) and alpha2(IV)NC1 (A) (green), alpha3(IV)NC1 (B, E) (green), alpha4(IV)NC1 (C, F, G) (green) and HLA-G (D)
(green). Cell nuclei were stained with DAPI (blue). VC e villous core, CCC e cytotrophoblast cell column.
C.M. Oefner et al. / Placenta 36 (2015) 59e68 653.5. Expression of collagen receptors by trophoblast
High-afﬁnity binding sites in collagen are recognised by re-
ceptors such as integrins which play an important role in mediating
trophoblast invasion [8,37]. Since the expression of integrins a10,
a11 and collagen receptors DDR-1 and DDR-2 by trophoblast is not
yet known, we examined their localisation by immunohistochem-
istry (Fig. 5). All these molecules are expressed by all trophoblast
types. Cells within the villous core also stain positive.
4. Discussion
In both trophoblast invasion and cancer metastasis the extent of
invasion depends on the intrinsic invasiveness of the cells and their
surrounding microenvironment [38e42]. Implantation in humans
is unique in that it is characterised by the onset of decidualisation in
non-pregnant endometrium and the intrinsic invasive potential of
trophoblast. Hence, successful placentation is determined by fac-
tors of both maternal and fetal origin.
Decidualisation is characterised by dramatic tissue remodelling
involving differentiation of glands, stroma, immune cells and blood
vessels [1]. This process is dependent on progesterone and beginsduring the secretory phase where the Streeter's columns surround
spiral arteries. We now show col-IV appears ﬁrst in this decidual-
ising sheath and in the media of arterial walls, the focus of
trophoblast cell invasion and remodelling of the arteries [5,43].
Quantitative qPCR demonstrated selective up-regulation of mRNAs
encoding alpha5(IV) and alpha6(IV) in mid secretory endometrium,
suggesting they are regulated by progesterone supported by pre-
vious observation [44]. There is a further change from secretory
endometrium to decidua when all six col-IV alpha chains were
however up-regulated.
Col-IV is always considered as a protein speciﬁcally localised to
the basal lamina [45,46]. We found immunostaining for col-IV at
unusual sites (both fetal and maternal) outside the basement
membrane including the placental villous core as previously
described [47,48]. However, in comparison to the well-known
two-dimensional structure of col-IV in basement membranes
we report a novel three-dimensional structure in the mesen-
chyme of placental villi [14,49]. The high abundance and novel
‘network’ structure of col-IV in the villous core is likely to be of
functional importance. Furthermore we found col-IV immuno-
staining around EVT and decidual stromal cells. The unusual
globular immunoreactivity around invading EVT is reminiscent of
Fig. 5. Expression of collagen receptors in placenta and implantation site. Serial sections of ﬁrst trimester placental villi, n ¼ 3, were stained for cytokeratin 7 (A), isotype control (B
and G), integrin a10 (C), integrin a11 (D), DDR-1 (E) and DDR-2 (F). Scale bars 30 mm. Serial sections of ﬁrst trimester implantation site, n ¼ 2, were stained for DDR-1 (red) and HLA-
G (green) (H), DDR-2 (red) and HLA-G (green) (I) and isotype control (J). Cell nuclei were stained with DAPI (blue). VC e villous core, CCC e cytotrophoblast cell column.
C.M. Oefner et al. / Placenta 36 (2015) 59e6866reports from cancer cells and has also been described in HLA-
G þ EVT in the distal part of placental cell columns [20,50e54].
These globules have a granular appearance and are localised to
the surface of trophoblast cells. Other reports describe these
globules to be composed of col-IV and laminin [55,56]. Since we
have demonstrated secretion of col-IV by primary HLA-Gþ
trophoblast cells in vitro we conclude that EVT in the columns
as well as invading into decidua basalis secrete this collagen.
Interestingly, granules of col-IV and laminin appear signiﬁcantly
less around EVT in tubal pregnancy, possibly associated with
uncontrolled invasion of trophoblast cells at extra-vs. intra-uter-
ine sites [57]. Although the role of these globules is not clear,
neutralising antibodies to col-IV do block trophoblast invasion
in vitro [8]. Thus, maternal ECM (decidua) as well as ECM secreted
by fetal trophoblasts themselves might mediate the migratory
behaviour of these invasive cells [58].Cleavage of collagen ﬁbrils can produce short NC1 domains that
act directly on target cells to regulate their migration [35,36,59,60].
In our study alpha1-3(IV) and alpha5(IV) domains are present in
CCC. Since EVT at the tip of CCC express integrin avb3, which binds
to alpha2(IV) and alpha3(IV) NC1 domains, a direct interactionwith
trophoblast is possible [59,61,62]. The collagen XVIII NC1 domain
(endostatin) is known to increase MMP-2 expression in trophoblast
cells and the alpha(IV) NC1 domains might similarly affect MMP
expression by EVT [56,63]. In decidua, although we demonstrated
the presence of all col-IV alpha chains, there was selective immu-
nostaining of NC1 domains. The alpha4(IV) NC1 domain is absent
and alpha3(IV) and alpha6(IV) NC1 domains appear only in decidua
basalis. EVT express MMP-2 and MMP-9 [56,64,65] which both
cleave alpha3(IV) NC1 domain [56,64e66]. Like alpha6(IV), the
alpha3(IV) domain, named tumstatin, exhibits anti-angiogenic
functions and inhibits the proliferation and invasion of human
C.M. Oefner et al. / Placenta 36 (2015) 59e68 67melanoma cells in vitro [17,35,36,67]. Alpha3(IV) NC1 domain is
recognised by integrin a6b1 expressed by EVT [20,68]. Thus,
trophoblast cells might selectively degrade alpha(IV) chains leading
to the exposure of alpha3(IV) and alpha6(IV) but not alpha4(IV)
NC1 domains at the implantation site. This might function as a self-
regulatory mechanism mediating a balanced trophoblast invasion.
Trophoblast ECM receptors have been studied previously but
not the expression of integrins a10 and a11 and collagen receptors
DDR-1 and DDR-2 [3,20,69]. These can bind to col-IV and are all
linked with the progression of cancer [26,27,70e73]. Interestingly,
DDR-1-null mice are unable to produce offspring due to a lack of
proper blastocyst implantation suggesting an important role for
DDR-1 in implantation [74]. Since EVT in cell columns express
integrin subunit b1 and integrins a10 and a11, as shown in this
study, it is likely that trophoblast cells express the a10b1 and a11b1
heterodimers [3,8]. Similar to the role of integrins and DDR re-
ceptors in cancer cell migration, the differential expression and
activation of collagen receptors in combination with the presence
of col-IV around trophoblast cells is likely to play a role in
trophoblast invasion.
In conclusion, this study provides new knowledge on maternal
and fetal factors that might affect trophoblast cell invasion. We
describe a novel arrangement for col-IV in the form of a three-
dimensional network in the villous mesenchyme. The secretion of
globular forms by migrating trophoblast cells suggests that col-IV
does not only represent a structural protein providing tissue
integrity. The complex interplay of col-IV secreted by trophoblast
cells, NC1 domains and their receptors might be involved in inﬂu-
encing the invasive behaviour of trophoblast cells at the implan-
tation site. Further investigations are needed to reveal the role of
these factors in mediating trophoblast cell invasion.Conﬂict of interest
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